Hexastatin-1

General Information


DRACP ID  DRACP04823

Peptide Name   Hexastatin-1

Sequence  ATPFIECSGARGTCHYFAN

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Homo sapiens (α6 CIV)

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C89H129N25O27S2

Absent amino acids  DKLMQVW

Common amino acids  A

Mass  236652

Pl  7.25

Basic residues  2

Acidic residues  1

Hydrophobic residues  6

Net charge  1

Boman Index  -2096

Hydrophobicity  -0.53

Aliphatic Index  36.32

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1615

Absorbance 280nm  89.72

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18780781

Title  A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells

Doi 10.1073/pnas.0803241105

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.